While p53 retains its wild-type form in nearly 50 % of tumors, TP53 remains the most frequently mutated gene in human cancers, where p53 function is often impaired or compromised (Herrero et al., 2016[77]; Wasylishen and Lozano, 2016[241]). This evidence concerns the gene TP53 and cancer.